NewVale Capital Fund II LP
RaisingEmerging manager
Raising: Form D reports no first sale yet
- Vintage
- Unknown
- Fund size
- $250M (Form D)
- Stages
- Not stated
- Sectors
- Life sciences and research tools
- Regions
- Not stated
01 · Thesis
NewVale Capital is a sector-specialist pharma services growth equity firm. It invests in proven, revenue-generating services and enabling technology businesses serving the life sciences ecosystem, in the window between commercial proof points and commercial scale.Inferred from the firm's website
02 · Initial check
$10M to $50M (stated by the firm)
Stated by the firm (firm-level)
03 · Who to approach
Named on this fund's Form D
- TODD HOLMES, MANAGER OF GENERAL PARTNER OF ISSUER
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideNewVale's debut fund invests in the services architecture of the life science industry. The fund was announced as oversubscribed.
NewVale Capital Debuts With Oversubscribed $167 Million Fund to Invest in the Services Architecture of the Life Science Industry
https://newvalecapital.com/news/Firm-wideChecks of $10000000 to $50000000
$10M to $50M equity investments
https://newvalecapital.com/approach/
06 · Sources
Last verified: Oct 28, 2026